The Establishment of Large-sample Database of "Multiple-MRI/Gene/Cognition"

August 2, 2022 updated by: Yu-Feng ZANG, Hangzhou Normal University
Aim to establish a large-sample database of "Multiple-MRI/Gene/Cognition" for healthy Chinese (sample number, 5000; age, 6-70 years). This is a fundamental but very necessary work for future researches such as development, aging, relation of gene and behavior, relation of gene and neuroimaging, relation of behavior and neuroimaging. Importantly, this work will provide a norm for researches on psychological or neurological patients. This large-sample will be shared with world-wide researchers.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

A part of data have been used in a publication which is preparing to submit.

Study Type

Observational

Enrollment (Anticipated)

5000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • China
    • Zhejiang
      • Hangzhou, Zhejiang, China, 310010
        • Recruiting
        • Hangzhou Normal University,Center for Cognition and Brain Disorder
        • Principal Investigator:
          • Yu-Feng ZANG, M.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 70 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Residents of Hangzhou, China.

Description

Inclusion Criteria:

  • Healthy Chinese
  • Age: 6-70 years old
  • Right handed
  • No smoking or alcoholic addiction

Exclusion Criteria:

  • Psychological or neurological patients
  • Hypertension or cardiopathy patients
  • Pregnant woman
  • Take medicine or drink tea/coffee before scanning-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Large-sample healthy participants
MRI scanning.
Device: MRI
fMRI, sMRI, ASL and DTI

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The distribution of the amplitude of blood oxygenation level dependent(BOLD) signal in healthy subjects
Time Frame: up to 15 months
The amplitude of BOLD-functional magnetic resonance imaging(fMRI) signal is a common measure to estimate the brain activity during resting-state. We try to establish its distribution on healthy subjects, which could be a control to examine abnormal brain function in patients.
up to 15 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hangzhou Normal University

Investigators

  • Principal Investigator: Yu-Feng ZANG, M.D., Hangzhou Normal University, Center for Cognition and Brain Disorder

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 8, 2014

Primary Completion (Actual)

August 2, 2022

Study Completion (Anticipated)

August 2, 2022

Study Registration Dates

First Submitted

May 14, 2014

First Submitted That Met QC Criteria

May 19, 2014

First Posted (Estimate)

May 22, 2014

Study Record Updates

Last Update Posted (Actual)

August 3, 2022

Last Update Submitted That Met QC Criteria

August 2, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • HNU_CCBD_LargeSampleCollection

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The data cannot be share with other researchers right now. It will be shared two years later.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on MRI

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe